Based on the power of attorney granted at the annual general meetings of
NattoPharma ASA ("NattoPharma" or "Company") on June 25, 2015 and May 20, 2016,
the Board of Directors of NattoPharma has in board proceedings June 24th, 2016
approved a share issue of 305 000 new shares, each with a face value of NOK 3
per share.
The share issue will be completed through issuance of new shares to leading
employees in accordance with the company’s incentive program according to the
following plan;
Name Position / Granted shares Shares prior Shares after
Function to share share issue
issue
Daniel H. CEO 0
Rosenbaum 100.000 100.000
Kjetil CFO 0
Ramsøy 100.000 100.000
Eric VP Sales & 0
Anderson Marketing 50.000 50.000
Rudi de VP Sales 0
Man Europe & 30.000 30.000
Asia
William VP Global 0
Sommer Development 25.000 25.000
and
Regulatory
Price to be paid for each share is NOK 3 per share. The share issue is expected
to be completed within July 31st, 2016.
As a result, the share capital will be increased by NOK 915 000. The Company’s
new share capital after the share issue will be NOK 52 334 799 divided into
17 444 933 shares, each with a face value of NOK 3.
* * *
For more information, please contact:
Kjetil Ramsøy, Chief Financial Officer
E-mail: kjetil.ramsoy@nattopharma.com
This information is subject of the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
SHARE ISSUE
| Source: NATTO PHARMA
Attachments
